Neuropace, based in Mountain View, CA, is a leading provider of the RNS System, the only FDA-approved epilepsy device that delivers personalized treatment by responding to abnormal brain activity and provides EEG data to improve patient care. With life-changing outcomes, the RNS System helps patients achieve significant seizure reduction and quality of life improvements through personalized treatment based on their unique seizure fingerprint.
By providing unprecedented visibility into seizure trends and triggers, the RNS System empowers physicians with actionable insights to optimize patient treatment plans. With endorsements from physicians and positive patient testimonials, Neuropace is revolutionizing the way epilepsy is treated, offering a smarter and more effective approach to managing drug-resistant focal epilepsy.
Generated from the website